Financial reports
NT 10-Q
Notice of late quarterly filing
16 May 24
ARS
2023 FY
Annual report to shareholders
22 Apr 24
10-K
2023 FY
Annual report
13 Mar 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
10 May 23
ARS
2022 FY
Annual report to shareholders
8 May 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
Current reports
8-K
Cue Health to Pursue Wind Down of the Business
28 May 24
8-K
Departure of Directors or Certain Officers
16 May 24
8-K
Cost Associated with Exit or Disposal Activities
1 May 24
8-K
Departure of Directors or Certain Officers
24 Apr 24
8-K
Entry into a Material Definitive Agreement
9 Apr 24
8-K
Departure of Directors or Certain Officers
29 Mar 24
8-K
Cue Health Announces Strategic Actions to Position Company for Next Stage
20 Mar 24
8-K
Cue Health Reports Fourth Quarter 2023 Financial Results
13 Mar 24
8-K
Cue Health Announces Appointment of Rishi Reddy to Board of Directors
16 Feb 24
8-K
Cost Associated with Exit or Disposal Activities
25 Jan 24
Registration and prospectus
8-A12B/A
Registration of securities on exchange (amended)
9 Apr 24
S-8
Registration of securities for employees
13 Mar 24
8-A12B
Registration of securities on exchange
21 Sep 23
424B5
Prospectus supplement for primary offering
9 Aug 23
S-3/A
Shelf registration (amended)
31 Jul 23
S-3
Shelf registration
16 Mar 23
S-8
Registration of securities for employees
16 Mar 23
S-8
Registration of securities for employees
29 Mar 22
424B4
Prospectus supplement with pricing info
27 Sep 21
S-8
Registration of securities for employees
24 Sep 21
Proxies
Other
EFFECT
Notice of effectiveness
7 Aug 23
CORRESP
Correspondence with SEC
2 Aug 23
UPLOAD
Letter from SEC
27 Mar 23
EFFECT
Notice of effectiveness
24 Sep 21
CERT
Certification of approval for exchange listing
22 Sep 21
CORRESP
Correspondence with SEC
21 Sep 21
CORRESP
Correspondence with SEC
21 Sep 21
CORRESP
Correspondence with SEC
15 Sep 21
CORRESP
Correspondence with SEC
15 Sep 21
UPLOAD
Letter from SEC
13 Sep 21